Need for Permanent Pacemaker as a Complication of Transcatheter Aortic Valve Implantation and Surgical Aortic Valve Replacement in Elderly Patients With Severe Aortic Stenosis and Similar Baseline Electrocardiographic Findings
Objectives The aim of this study was to compare the incidence and predictive factors of complete atrioventricular block (AVB) and permanent pacemaker implantation (PPI) after transcatheter aortic valve implantation (TAVI) versus surgical aortic valve replacement (SAVR).
Background No data exist on the need for PPI after TAVI versus SAVR in patients with similar baseline electrocardiographic (ECG) findings.
Methods A total of 411 patients with severe aortic stenosis (AS) and no prior pacemaker who underwent TAVI with the balloon-expandable Edwards valve (Edwards Lifesciences, Irvine, California) were matched (1:1) with 411 elderly patients with severe AS who underwent isolated SAVR on the basis of baseline ECG findings. The incidence, reasons, and predictive factors for PPI within 30 days after the procedure were compared between groups.
Results Mean age was similar in both groups (p ϭ 0.11), and the TAVI group had a higher Society of Thoracic Surgeons score (p Ͻ 0.001). The rate of new PPI was higher after TAVI (7.3%) compared with SAVR (3.4%), p ϭ 0.014. Complete AVB and severe symptomatic bradycardia, respectively, were the reasons for PPI in the TAVI (5.6% and 1.7%, respectively) and SAVR (2.7% and 0.7%, respectively) groups (p ϭ 0.039 for complete AVB, p ϭ NS for symptomatic bradycardia). The presence of baseline right bundle branch block was the only variable associated with PPI in the TAVI group (odds ratio: 8.61, 95% confidence interval: 3.14 to 23.67, p Ͻ 0.0001), whereas no variable was found in the SAVR group.
Conclusions Transcatheter aortic valve implantation was associated with a higher rate of complete AVB and PPI compared with SAVR in elderly patients with severe AS and similar baseline ECG findings. The presence of baseline right bundle branch block correlated with the need for PPI in the TAVI group. The occurrence of conduction abnormalities leading to the need for permanent pacemaker implantation (PPI) remains one of the most concerning complications associated with transcatheter aortic valve implantation (TAVI), with an incidence ranging from 9.3% to 42% among those patients undergoing the procedure with a self-expandable valve (CoreValve, Medtronic, Minneapolis, Minnesota) (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) and from 2.5% to 11.5% after TAVI with a balloonexpandable valve (Edwards valve, Edwards Lifesciences, Irvine, California) (6, 7, (12) (13) (14) (15) (16) . Therefore, it would be of high clinical relevance to determine the predictive factors of conduction abnormalities and the need for PPI after a TAVI procedure. Although some studies have already identified several variables associated with the need for PPI after TAVI with a self-expandable prosthesis (2) (3) (4) (5) (6) 8, 11) , very few data exist on the prediction of such a complication after TAVI with a balloon-expandable valve. The occurrence of conduction disturbances and PPI is also a well-known complication after surgical aortic valve replacement (SAVR), with an incidence ranging from 3.2% to 8.5% (17) (18) (19) (20) (21) (22) (23) . However, most SAVR studies have included patients of very different ages and those undergoing coronary artery bypass grafting during the same intervention as well as those with both aortic stenosis (AS) and/or insufficiency as the predominant underlying aortic valve disease. Therefore, very few data exist on the post-operative need for PPI in elderly patients undergoing isolated SAVR because of pure/predominant severe AS, which has been the population selected for TAVI up to now. Thus, the aims of this study were: 1) to compare the incidence of PPI among elderly patients with severe symptomatic AS and similar baseline electrocardiographic (ECG) abnormalities undergoing TAVI versus isolated SAVR; and 2) to determine factors associated with PPI after TAVI and SAVR. Of these, 140 patients were excluded for the following reasons: prior pacemaker, cardiac resynchronizations and/or implantable cardioverter-defibrillators (n ϭ 106), "valve-in-a-valve" procedures for prior failed surgical bioprosthesis (n ϭ 17), and unsuccessful procedures leading to either procedural death or no valve implantation and precluding the analysis of post-procedural conduction disturbances and PPI (n ϭ 17). Therefore, the final TAVI study population consisted of 411 patients (Fig. 1) . All clinical, echocardiographic, procedural, and post-procedural data were prospectively gathered. The TAVI procedures have been described in detail in previous reports (12) . Temporary transvenous pacing was established, and valve implantation was performed under rapid ventricular pacing (160 to 220 beats/ min) in all cases. The temporary pacemaker was removed at the end of the TAVI procedure, and all patients were placed on continuous ECG monitoring until hospital discharge.
The occurrence and timing of post-operative conduction disturbances leading to PPI were prospectively recorded, as were the occurrence and timing of post-operative conduction disturbances managed by temporary pacing. The policies for PPI were in accordance with the American College of Cardiology/American Heart Association/Heart Rhythm Society guidelines for device-based therapy of cardiac rhythm abnormalities (24) , and PPI was indicated for third-degree and advanced second-degree atrioventricular block (AVB) at any anatomic level associated with postoperative AVB that was not expected to resolve after the intervention and for sinus node dysfunction with documented symptomatic bradycardia (SB), including frequent sinus pauses that produced symptoms. SAVR population. A total of 900 consecutive elderly (Ͼ70 years of age) patients underwent isolated SAVR for severe symptomatic AS (as a predominant lesion) at the Quebec Heart and Lung Institute between 2002 and 2010. The clinical, echocardiographic, procedural, and post-procedural data of all these patients had been prospectively gathered in a database. A total of 120 patients were excluded for the following reasons: prior SAVR (n ϭ 38); prior pacemaker, cardiac resynchronizations, or implantable cardioverterdefibrillators (n ϭ 65); and concomitant aortic root replacement procedures (n ϭ 17), leading to a cohort of 780 SAVR patients (Fig. 1) .
Surgical AVR procedures were performed through a midline sternotomy, with standard techniques. Temporary epicardial leads were inserted at the end of the intervention in all patients and maintained until hospital discharge. The patients were placed on continuous ECG monitoring until hospital discharge. The occurrence and timing of post- operative conduction disturbances leading to PPI were prospectively recorded, as were the occurrence and timing of post-operative conduction disturbances managed by temporary pacing. The policies for PPI followed the same criteria as for the TAVI population (24) . Matching process for baseline ECG findings. For the purpose of this study the baseline ECGs obtained within the 24 h before TAVI and SAVR were analyzed by 2 investigators unaware of the clinical data for the presence of conduction abnormalities as defined by the American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society recommendations for the standardization and interpretation of the ECG (25) . Patients were classified with respect to the presence of baseline conduction disturbances as follows: no conduction disturbances, left bundle branch block (LBBB), first-degree atrioventricular block (1-AVB), right bundle branch block (RBBB), left anterior hemiblock (LAH), intraventricular conduction disturbance (IVCD) (defined as the presence of QRS duration Ͼ110 ms without a pattern with RBBB or LBBB criteria) (25) , LBBB ϩ 1-AVB, RBBB ϩ 1-AVB, RBBB ϩ LAH, RBBB ϩ LAH ϩ 1-AVB, LAH ϩ 1-AVB, and IVCD ϩ 1-AVB (Table 1) . Within each ECG-subgroup, each TAVI patient was matched (1:1 ratio) with an SAVR patient with identical ECG findings. Considering that there was more than 1 SAVR patient who could potentially be matched with each TAVI patient in 9 of the 12 ECG-subgroups (Table 1) , the final matching was performed by random sampling without replacement with the bootstrap method. This led to a final study population of 411 patients/group with identical ECG findings ( Fig. 1 ).
Statistical analysis. Qualitative variables were expressed as percentages, and quantitative variables were expressed as mean Ϯ SD or median (25th to 75th interquartile range [IQR]), depending on variable distribution. The normality of distribution of continuous variables was verified with the Shapiro-Wilk test, and logarithmic transformation was performed if necessary. Continuous variables were compared with the Student t test or Wilcoxon rank-sum test for independent samples and the paired Student t test for matched groups and comparisons within groups. Categorical data were compared with the chi-square or Fischer exact tests for independent samples and the conditional logistic regression analysis for matched groups. A stepwise logistic regression analysis, including all variables with a p value Ͻ0.2 in the univariate analysis, was used to determine the independent predictors of PPI in both TAVI and SAVR groups. The variables included into the multivariate model were no conductions disturbances, RBBB and RBBB ϩ 1-AVB ϩ LAH for the TAVI group, and prior coronary artery bypass grafting and RBBB ϩ 1-AVB for the SAVR group. A propensity score analysis was performed to adjust for the intergroup (TAVI vs. SAVR) differences in baseline characteristics caused by the selection bias inherent to the nonrandomized nature of the study. A propensity score representing the likelihood of having TAVI as opposed to SAVR was calculated for each patient with a logistic regression analysis that identified variables independently associated with the type of procedure. Variables exhibiting a p value Ͻ0.2 in the univariate analysis were included in the logistic regression analysis. Body mass index, hypertension, previous myocardial infarction, previous open heart surgery, previous percutaneous coronary intervention, cerebrovascular disease, chronic obstructive pulmonary disease, chronic kidney disease, aortic valve area, and pulmonary hypertension were independently associated with the type of procedure and were used to calculate the propensity score. The calculated propensity score was then incorporated into the multivariable regression model, and PPI rate at 30 days was analyzed with a logistic regression analysis adjusted for propensity score.
Differences were considered statistically significant at p values Ͻ0.05. The data were analyzed with SAS statistical software (version 9.2, SAS Institute, Inc., Cary, North Carolina).
Results
Baseline clinical and echocardiographic characteristics of the study population and the main procedural data according to the type of procedure (TAVI vs. SAVR) are shown in Table 2 . The echocardiography performed at hospital discharge showed a significant reduction in mean aortic gradient (TAVI: from 44 Ϯ 16 mm Hg to 11 Ϯ 4 mm Hg; SAVR: from 48 Ϯ 16 mm Hg to 14 Ϯ 5 mm Hg, p Ͻ ) conduction disturbances leading to PPI occurred during the procedure (complete AVB, median 0 h, IQR: 0 to 24 h) and were managed either conservatively or with temporary pacing for a median of 2 days (IQR: 0 to 2 days) until PPI. The timing of procedural complete AVB (available in 17 patients) was as follows: 1) after crossing the native aortic valve with the straight wire (n ϭ 2); 2) immediately after balloon valvuloplasty (n ϭ 9); and 3) immediately after valve prosthesis deployment (n ϭ 6). In the remaining 8 patients (27%) conduction disturbances leading to PPI occurred at a median time of 60 h (IQR: 24 to 96 h) and were managed either conservatively or with temporary pacing until PPI. Among the SAVR group, conduction disturbances leading to PPI occurred at a median of 12 h (IQR: 0 to 24 h) after the procedure (p ϭ 0.36 compared with TAVI) and were managed either conservatively or with temporary pacing during a median of 6 days (IQR: 4 to 9 days) until PPI (p Ͻ 0.001 compared with TAVI). The PPI was performed Values are mean Ϯ (SD), n (%), or median (25th to 75th interquartile range), unless otherwise noted.
EuroSCORE ϭ European system for cardiac operative risk evaluation; NYHA ϭ New York Heart
Association functional class; SAVR ϭ surgical aortic valve replacement; STS ϭ Society of Thoracic Surgeons; TAVI ϭ transcatheter aortic valve implantation. Figures 3 and 4 , respectively. Data about the rhythm at hospital discharge were available in 31 of the 44 patients who had PPI during index hospital stay (20 in the TAVI group, and 11 in the SAVR group). In the TAVI group, 80% of the patients who required PPI were under pace-rhythm at hospital discharge (94% if PPI was due to complete AVB, and 25% if PPI was due to severe bradycardia) (Fig. 5 ). In the SAVR group, 73% of the patients who required PPI were under pace-rhythm at hospital discharge (70% if PPI was due to complete AVB, and 100% if PPI was due to severe bradycardia) (Fig. 5 ).
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In the SAVR group, 17 patients (4.1%) complicated with transient high-degree/complete AVB (n ϭ 6) or severe SB (n ϭ 11) that were managed with temporary pacing, with no need for later PPI. The median time from SAVR to these transient conduction abnormalities was 24 h (IQR: 24 to 48 h), and the median duration for temporary pacing was 36 h (IQR: 3 to 60 h). In the TAVI group, 2 patients (0.5%) presented with transient complete AVB during the procedure that was managed only with temporary pacing for a few minutes, with no PPI (p Ͻ 0.001 vs. SAVR). Factors associated with PPI after TAVI and SAVR. Clinical, echocardiographic, baseline ECG findings and procedural variables of the TAVI population grouped according to the need for PPI after the procedures are shown in Table 3 . In the multivariate analysis, RBBB was the only independent variable associated with PPI after TAVI (OR: 8.61, 95% CI: 3.14 to 23.67, p Ͻ 0.0001). Clinical, echocardiographic, baseline ECG findings and procedural variables of the SAVR population grouped according to the need for PPI are shown in Table 4 . No variable was found to be associated with PPI after SAVR in the multivariate analysis.
Discussion
This multicenter case-match study-including a large cohort of elderly patients diagnosed with severe symptomatic AS, no prior pacemaker, and similar baseline ECG findings-showed that TAVI was associated with a higher rate of PPI (7.3%) compared with SAVR (3.4%). The main reason for PPI was complete AVB (TAVI: 5.6%, SAVR: 2.7%), followed by severe SB (TAVI: 1.7%, SAVR: 0.7%). In both groups, most conduction disturbances leading to PPI occurred either during or within the 24 h after the procedure, but PPI was performed earlier in the TAVI group (2 days) compared with the SAVR group (6 days). Of note, no episodes of complete AVB occurred after 48 h after TAVI. Also, the use of temporary pacing for the management of transient complete AVB or severe SB was more frequent in the SAVR group (4.1%) compared with the TAVI group (0.5%). The presence of RBBB at baseline ECG was associated with PPI in the TAVI group, whereas no variable was found to be associated with PPI in the SAVR group. PPI after TAVI. Previous studies on TAVI using the balloonexpandable Edwards valve have reported a rate of PPI within the 30 days after the procedure of between 2.5% and 11.5%, although most studies did not exclude those patients with pre-procedural pacemaker from the PPI analysis (6, 7, (12) (13) (14) (15) (16) . Also in accordance with previous studies, the present study has shown that the occurrence of complete AVB was the reason for PPI in most cases. Interestingly, it has been shown that TAVI with a balloon-expandable valve is associated with the occurrence of new conduction disturbances, specifically new complete LBBB, in 12% to 21% of patients (6, 14, 26) . Any direct trauma or mechanical stress to the His-bundle at the region of the membranous septum and right trigone beneath the noncoronary/right coronary cusps (Fig. 6 ) might explain the occurrence of new conduction abnormalities leading to complete AVB after TAVI. The present study has shown that the vast majority (87%) of complete AVBs occurred at the time of the TAVI procedure, further supporting the mechanism of direct trauma to the conduction system during balloon dilation/valve expansion as the main cause for the conduction disturbances leading to PPI. Importantly, the rate of conduction disturbances and PPI after TAVI might vary according to the type of transcatheter valve. While TAVI with a balloonexpandable valve (Edwards valve) has been nearly systematically associated with an incidence of PPI lower than 10% (6, 7, (12) (13) (14) (15) (16) , the use of the self-expandable CoreValve prosthesis has been associated with a rate of PPI of approximately 25%, ranging from 9.3% to up to 42% (1-11). These differences might be explained by differences in the design of the 2 devices, with the CoreValve being a much longer device with a longer segment of the stent containing the valve entering into the left ventricular outflow tract and potentially increasing the interference with the conduction system. Also, the stent containing the CoreValve prosthesis is made of nitinol, which might result in continued outward N S , V O L . 5 , N O . 5 , 2 0 1 2   M A Y 2 0 1 2 : 5 4 0 -5 1 Bagur et al. Pacemaker Implantation: TAVI Versus SAVR pressure and expansion after valve deployment. This might partially explain why a significant number of conduction disturbances leading to PPI after CoreValve implantation occur not only at the time of the procedure but during the following days (4, 5, 27, 28) . This might translate into differences with regard to the management and monitoring of patients after the procedure, depending on the type of transcatheter valve. Smith et al. (29) reported similar rates of PPI in patients undergoing TAVI with a balloonexpandable valve (3.8%) versus SAVR (3.6%) in the PARTNER (Placement of Aortic Transcatheter Valve) trial. However, up to 21% of the patients had prior pacemaker and no data on baseline ECG and conduction disturbances before the TAVI procedure were provided. Also, the PPI rate observed in the PARTNER trial was among the lowest ever reported after TAVI with a balloonexpandable valve (6, 7, (12) (13) (14) (15) (16) . Unlike TAVI registries that included consecutive series of patients, the PARTNER trial included a selected group of patients, and one might wonder whether this could have influenced the PPI results.
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Very few studies including a small number of patients have evaluated the pre-procedural predictors of PPI after TAVI with a balloon-expandable valve (6, 14) . The present study showed, for the first time, that the presence of pre-existing RBBB independently correlated with a higher risk of complete AVB and PPI after TAVI with a balloonexpandable valve. Thirty-five percent of the patients with prior RBBB had complete AVB and needed PPI after the procedure, compared with only 5.9% of the patients with no prior RBBB. This is in accordance with the study that reported the occurrence of new LBBB in up to 21% of the patients after TAVI with a balloon-expandable valve (26) . Prior studies with the CoreValve prosthesis also identified the presence of RBBB as one of the main predictors of PPI after TAVI (5, 6, 8, 11) . PPI after SAVR. The occurrence of conduction disturbances and the need for PPI is a well-known complication after cardiac surgery (17) (18) (19) (20) (21) (22) , but most studies including SAVR patients have also included coronary artery bypass grafting as a concomitant intervention. Keefe et al. (18) and Dawkins et al. (22) reported a PPI rate of 3.3% and 8.5%, respectively, after isolated SAVR. However, both studies included patients with a wide age range as well as aortic stenosis and regurgitation as the main underlying aortic diseases. It is well known that aortic regurgitation is one of the most important predictive factors of PPI after SAVR (21) . We have previously reported a PPI rate of 3.2% after isolated SAVR in elderly patients with severe AS (23) . In accordance with these results, the incidence of PPI in the surgical cohort of the PARTNER trial was 3.6% (29) . The present study, which evaluated the occurrence of conduction disturbances and the need for PPI in elderly patients undergoing isolated SAVR due to AS, showed a PPI rate of 3.4% after the intervention. Most patients underwent PPI due to complete AVB, and a minority underwent PPI because of severe SB. Although several previous studies had identified the presence of baseline conduction disturbances as a predictor of PPI after SAVR (17, 20, 22, 23) , we failed to identify any independent predictive factor of PPI in our study. This probably highlights the importance of technical procedural aspects as well as the severity of valve calcification in the occurrence of some injury of the conduction system during the procedure leading to conduction abnormalities and PPI. Importantly, unlike TAVI procedures, only one-half of the AV conduction abnormalities occurred during the procedure, whereas the other one-half occurred within the first few hours/days after the procedure. Study limitations. Although baseline and procedural data had been prospectively collected, one of the main limitations of the study lies in the nonrandomized nature of the comparison between TAVI and SAVR, which led to significant differences in between-group baseline characteristics. Also, the low number of events (n ϭ 14) contributed to the inability to identify factors associated with PPI after SAVR. Although SAVR patients had systematic temporary epicardial leads in place up to hospital discharge, temporary Values are n (%), mean Ϯ (SD), or median (25th to 75th interquartile range).
PPI ϭ permanent pacemaker implantation; other abbreviations as in Tables 1 and 2 . pacemaker leads were routinely removed after the TAVI procedure in the absence of procedural conduction abnormalities. A potential influence of these differences in temporary pacing on the final rate of PPI between groups cannot be excluded. However, most conduction disturbances in the TAVI group occurred during the procedure and most patients were initially managed either conservatively or with temporary pacing for a median of 2 days before PPI. Also, the vast majority (Ͼ90%) of the patients who had PPI due to complete AVB were in paced rhythm at hospital discharge. Therefore, it is unlikely that differences in temporary pacing management would have had a significant influence on the differences in PPI between groups. Finally, no assessment was made on valve calcification pattern/distribution and the ventricular depth of the valve prosthesis, which have been identified as predictors of conduction abnormalities and PPI after TAVI (2, 3, 8) . The absence of standardized echocardiographic and/or angiographic images at the end of the TAVI procedure among the participating centers precluded a reliable measurement of the ventricular depth of the valve prosthesis in the present study.
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Conclusions
Transcatheter aortic valve implantation with a balloonexpandable valve was complicated with the need for PPI after the procedure in 7.3% of the patients, a rate significantly higher than the rate of 3.4% observed in SAVR patients with similar baseline ECG abnormalities. Most patients in both groups needed PPI because of complete AVB occurring either during or within 24 h after the procedure in most cases. Finally, the presence of preexisting RBBB was a powerful risk factor for PPI in the TAVI group but not in the SAVR group. Transcatheter Values are n (%), mean Ϯ (SD), or median (25th to 75th interquartile range).
Abbreviations as in Tables 1, 2 , and 3.
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aortic valve implantation has become a well-established treatment for very high-or prohibitive-surgical-risk patients with AS and might become an option for a lower-risk population in the near future. These results should help to better identify the patients at risk for PPI after the procedure and contribute to an improved clinical decision making process in patients eligible for either TAVI or SAVR.
